Transglutaminase inhibition: possible therapeutic mechanisms to protect cells from death in neurological disorders `
Open Access
- 1 January 2017
- journal article
- Published by Heighten Science Publications Corporation
- Vol. 1 (1), 026-038
- https://doi.org/10.29328/journal.hjbm.1001004
Abstract
No abstract availableThis publication has 86 references indexed in Scilit:
- Tissue Transglutaminase Constitutively Activates HIF-1α Promoter and Nuclear Factor-κB via a Non-Canonical PathwayPLOS ONE, 2012
- Transglutaminase Inhibition Protects against Oxidative Stress-Induced Neuronal Death Downstream of Pathological ERK ActivationJournal of Neuroscience, 2012
- Transglutaminase 6: a protein associated with central nervous system development and motor functionAmino Acids, 2011
- Anti Transglutaminase Antibodies Cause Ataxia in MicePLOS ONE, 2010
- Tissue transglutaminase modulates α‐synuclein oligomerizationProtein Science, 2008
- Pathogenesis of Inclusion Bodies in (CAG)n/Qn-Expansion Diseases with Special Reference to the Role of Tissue Transglutaminase and to Selective VulnerabilityJournal of Neurochemistry, 2008
- Transglutaminase Induces Protofibril-like Amyloid β-Protein Assemblies That Are Protease-resistant and Inhibit Long-term PotentiationOnline Journal of Public Health Informatics, 2008
- Increased levels of γ‐glutamylamines in Huntington disease CSFJournal of Neurochemistry, 2008
- Transglutaminases: crosslinking enzymes with pleiotropic functionsNature Reviews Molecular Cell Biology, 2003
- tTGase/Gαh protein expression inhibits adenylate cyclase activity in Balb-C 3T3 fibroblasts membranesBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1997